These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 19803719)

  • 21. Prevalence of latent tuberculosis infection among healthcare workers in China as detected by two interferon-gamma release assays.
    Wei Z; Yang M; Quan B; Wang Y; Wu Y; Ji B
    J Hosp Infect; 2013 Aug; 84(4):323-5. PubMed ID: 23806839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of rituximab therapy on released interferon-γ levels in the QuantiFERON assay among RA patients with different status of Mycobacterium tuberculosis infection.
    Chen YM; Chen HH; Lai KL; Hung WT; Lan JL; Chen DY
    Rheumatology (Oxford); 2013 Apr; 52(4):697-704. PubMed ID: 23264552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The QuantiFERON-TB Gold In-Tube Assay in Neuro-Ophthalmology.
    Little LM; Rigi M; Suleiman A; Smith SV; Graviss EA; Foroozan R; Lee AG
    J Neuroophthalmol; 2017 Sep; 37(3):242-246. PubMed ID: 28079759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
    Sato S; Nagai H
    Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening for tuberculosis infection using whole-blood interferon-gamma and Mantoux testing among Japanese healthcare workers.
    Harada N; Nakajima Y; Higuchi K; Sekiya Y; Rothel J; Mori T
    Infect Control Hosp Epidemiol; 2006 May; 27(5):442-8. PubMed ID: 16671023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon-γ release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States.
    Dorman SE; Belknap R; Graviss EA; Reves R; Schluger N; Weinfurter P; Wang Y; Cronin W; Hirsch-Moverman Y; Teeter LD; Parker M; Garrett DO; Daley CL;
    Am J Respir Crit Care Med; 2014 Jan; 189(1):77-87. PubMed ID: 24299555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of the QuantiFERON-TB Gold interferon-gamma release assay for screening transplant candidates: a single-center retrospective study.
    Theodoropoulos N; Lanternier F; Rassiwala J; McNatt G; Preczewski L; DeMayo E; Stosor V; Ison MG
    Transpl Infect Dis; 2012 Feb; 14(1):1-8. PubMed ID: 21883759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multicentre verification study of the QuantiFERON
    Pieterman ED; Liqui Lung FG; Verbon A; Bax HI; Ang CW; Berkhout J; Blaauw G; Brandenburg A; van Burgel ND; Claessen A; van Dijk K; Heron M; Hooghiemstra M; Leussenkamp-Hummelink R; van Lochem E; van Loo IHM; Mulder B; Ott A; Pontesilli O; Reuwer A; Rombouts P; Saegeman V; Scholing M; Vainio S; de Steenwinkel JEM
    Tuberculosis (Edinb); 2018 Jan; 108():136-142. PubMed ID: 29523314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of QuantiFERON-TB Gold with tuberculin skin test for detection of latent tuberculosis infection before kidney transplantation.
    Kim JS; Cho JH; Park GY; Kang YJ; Kwon O; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Kim CD
    Transplant Proc; 2013 Oct; 45(8):2899-902. PubMed ID: 24157000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population.
    Ponce de Leon D; Acevedo-Vasquez E; Alvizuri S; Gutierrez C; Cucho M; Alfaro J; Perich R; Sanchez-Torres A; Pastor C; Sanchez-Schwartz C; Medina M; Gamboa R; Ugarte M
    J Rheumatol; 2008 May; 35(5):776-81. PubMed ID: 18398944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality control in QuantiFERON-TB gold in-tube for screening latent tuberculosis infection in health care workers.
    Igari H; Watanabe A; Ichimura Y; Sakurai T; Taniguchi T; Ishiwada N
    J Infect Chemother; 2017 Apr; 23(4):211-213. PubMed ID: 28094124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the interferon- gamma release assay and the tuberculin skin test for contact investigation of tuberculosis in BCG-vaccinated health care workers.
    Lee SS; Liu YC; Huang TS; Chen YS; Tsai HC; Wann SR; Lin HH
    Scand J Infect Dis; 2008; 40(5):373-80. PubMed ID: 18418798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective comparison of the tuberculin skin test and 2 whole-blood interferon-gamma release assays in persons with suspected tuberculosis.
    Mazurek GH; Weis SE; Moonan PK; Daley CL; Bernardo J; Lardizabal AA; Reves RR; Toney SR; Daniels LJ; LoBue PA
    Clin Infect Dis; 2007 Oct; 45(7):837-45. PubMed ID: 17806047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective large-scale study of methods for the detection of latent Mycobacterium tuberculosis infection in refugee children.
    Lucas M; Nicol P; McKinnon E; Whidborne R; Lucas A; Thambiran A; Burgner D; Waring J; French M
    Thorax; 2010 May; 65(5):442-8. PubMed ID: 20435869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. QuantiFERON-TB Gold assay for the diagnosis of latent tuberculosis infection.
    Manuel O; Kumar D
    Expert Rev Mol Diagn; 2008 May; 8(3):247-56. PubMed ID: 18598104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting the Development of Tuberculosis with the Tuberculin Skin Test and QuantiFERON Testing.
    Altet N; Dominguez J; Souza-Galvão ML; Jiménez-Fuentes MÁ; Milà C; Solsona J; Soriano-Arandés A; Latorre I; Lara E; Cantos A; Ferrer MD; Orcau À; Ruiz-Manzano J; Caylà J
    Ann Am Thorac Soc; 2015 May; 12(5):680-8. PubMed ID: 25699406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Direct Comparison of Two Interferon-gamma Release Assays in the Tuberculosis Screening of Japanese Healthcare Workers.
    Tanabe M; Nakamura A; Arai A; Yamasaki D; Hirano K; Kobayashi T; Taguchi O; Kaneko T; Ito M
    Intern Med; 2017; 56(7):773-779. PubMed ID: 28381742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases.
    Bartalesi F; Vicidomini S; Goletti D; Fiorelli C; Fiori G; Melchiorre D; Tortoli E; Mantella A; Benucci M; Girardi E; Cerinic MM; Bartoloni A
    Eur Respir J; 2009 Mar; 33(3):586-93. PubMed ID: 19047313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of IGRA tests and TST in the diagnosis of latent tuberculosis infection and predicting tuberculosis in risk groups in Krakow, Poland.
    Kruczak K; Duplaga M; Sanak M; Cmiel A; Mastalerz L; Sladek K; Nizankowska-Mogilnicka E
    Scand J Infect Dis; 2014 Sep; 46(9):649-55. PubMed ID: 25073535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.